European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant antibody derivative against human CD19 and CD3
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant antibody derivative against human CD19 and CD3
| EU orphan designation number: | EU/3/03/175
|
| Active ingredient: | Recombinant antibody derivative against human CD19 and CD3 |
| Indication: | Treatment of mantle cell lymphoma |
| Sponsor: | AMGEN Research (Munich) Gmbh
Staffelseestrasse 2, D-81477 München, Deutschland |
Public summary of scientific opinion
